SCHEMBL7017759

SCHEMBL7017759

Cc1ccc(-c2ccccc2-n2c(C)n[nH]c2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
TDP1 Q9NUW8 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HSP90AA1 P07900 4/20 0.41
CYP2C9 P11712 1/20 0.40
POLB P06746 1/20 0.40
RET P07949 1/20 0.39
MET P08581 1/20 0.39
LTK P29376 1/20 0.39
GRK5 P34947 1/20 0.39
CDK8 P49336 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MST1R Q04912 1/20 0.39
TYRO3 Q06418 1/20 0.39
DYRK1A Q13627 1/20 0.39
LRRK2 Q5S007 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
ALK Q9UM73 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133465 0.76 HSP90AA1 (0.56) CYP1A2TDP1L3MBTL1NPC1RAB9A
SCHEMBL7015129 0.75 LMNA (0.47) NPC1RAB9ARETMETLTK
SCHEMBL12692935 0.75 HSP90AA1 (0.57) CYP1A2TDP1L3MBTL1NPC1RAB9A
SCHEMBL7015535 0.71 ALDH1A1 (0.45) L3MBTL1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL24174132 0.68 MAPT (0.45) CYP1A2L3MBTL1POLBSMN1; SMN2ALDH1A1
SCHEMBL7013941 0.67 NOTUM (0.71)
SCHEMBL11703583 0.66 HPGD (0.52) L3MBTL1HSP90AA1MEN1KMT2AALDH1A1
SCHEMBL2896019 0.65 HSD17B10 (0.65) TDP1POLBSMN1; SMN2MEN1KMT2A
SCHEMBL8036362 0.64 LMNA (0.50) TDP1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL11707694 0.63 HSP90AA1 (0.48) HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5736555-A HYPOTENSIVE AGENTS; FDA ORANGE BOOK LISTED PATENT FOR AZILSARTAN MEDOXOMIL TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-07 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed